Showing results (81-90 of 181) with videos related to
Sort By:
Pageof 19
Cancer Research|December 20, 2007
Tumor irradiation increases the recruitment of circulating mesenchymal stem cells into the tumor microenvironmentAnn H Klopp, Erika L Spaeth, Jennifer L Dembinski, et al.International Journal of Radiation Oncology, Biology, Physics|March 17, 2012
Changes in pulmonary function after three-dimensional conformal radiotherapy, intensity-modulated radiotherapy, or proton beam therapy for non-small-cell lung cancerJose L Lopez Guerra, Daniel R Gomez, Yan Zhuang, et al.International Journal of Radiation Oncology, Biology, Physics|July 7, 2009
Long-term toxicity following 3D conformal radiation therapy for prostate cancer from the RTOG 9406 phase I/II dose escalation studyJeff M Michalski, Kyounghwa Bae, Mack Roach, et al.International Journal of Radiation Oncology, Biology, Physics|October 20, 2009
Impact of toxicity grade and scoring system on the relationship between mean lung dose and risk of radiation pneumonitis in a large cohort of patients with non-small cell lung cancerSusan L Tucker, Hekun Jin, Xiong Wei, et al.International Journal of Radiation Oncology, Biology, Physics|August 8, 2013
Comparison of 2 common radiation therapy techniques for definitive treatment of small cell lung cancerShervin M Shirvani, Aditya Juloori, Pamela K Allen, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 23, 2011
Functional promoter rs2868371 variant of HSPB1 associates with radiation-induced esophageal toxicity in patients with non-small-cell lung cancer treated with radio(chemo)therapyJose Luis Lopez Guerra, Qingyi Wei, Xianglin Yuan, et al.Physics in Medicine and Biology|March 24, 2009
The risk of developing a second cancer after receiving craniospinal proton irradiationWayne D Newhauser, Jonas D Fontenot, Anita Mahajan, et al.Leukemia & Lymphoma|April 11, 2003
Outcomes using doxorubicin-based chemotherapy with or without radiotherapy for early-stage peripheral T-cell lymphomasHoon K Lee, Richard B Wilder, Dan Jones, et al.Cancer|March 29, 2002
European Organization for Research and Treatment of Cancer and Groupe d'Etude des Lymphomes de l'Adulte very favorable and favorable, lymphocyte-predominant Hodgkin diseaseRichard B Wilder, Pamela J Schlembach, Dan Jones, et al.International Journal of Radiation Oncology, Biology, Physics|August 8, 2012
Propensity score-based comparison of long-term outcomes with 3-dimensional conformal radiotherapy vs intensity-modulated radiotherapy for esophageal cancerSteven H Lin, Lu Wang, Bevan Myles, et al.Pageof 19